ABIGAIL AVERY: Open Payments
NPI 1922708858 · HENDERSON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,262 in 59 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $1,678 · 2025 $1,262
Food & beverage: $1,262
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $401 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $225 |
| ABBVIE INC. | 8 | $137 |
| PFIZER INC. | 6 | $118 |
| Lilly USA, LLC | 4 | $63 |
| GlaxoSmithKline, LLC. | 3 | $59 |
| Corcept Therapeutics | 2 | $54 |
| Esperion Therapeutics, Inc. | 3 | $49 |
| Exact Sciences Corporation | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 2 | $35 |
Products named: CAPLYTA, Wegovy, Ozempic, VRAYLAR, NURTEC ODT, MOUNJARO, TRELEGY ELLIPTA, Korlym.
Industry payments across NC — which companies pay providers there.
